Status:
COMPLETED
Application of Hyperoxygenated Fatty Acids in a Surgical Wound After Laparoscopic Cholecystectomy.
Lead Sponsor:
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Conditions:
Surgical Site Infection
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
TITLE: Application of hyperoxygenated fatty acids (PrevOmega) in a surgical wound of the umbilical trocar after laparoscopic cholecystectomy with placement of prostheses in patients with risk factors...
Detailed Description
This study aimed to evaluate the effect of topical application of hyperoxygenated fatty acids (AGHO), PrevOmega, at the umbilical trocar level after laparoscopic cholecystectomy with prosthesis placem...
Eligibility Criteria
Inclusion
- Patients with ages between 18 and 90 years who underwent elective laparoscopic cholecystectomy for symptomatic cholelithiasis and who also presented any of the following risk factors for SSI or EOT were included:
- Obesity with body mass index (BMI)\> 30kg / m2
- Diabetes Mellitus (insulin dependent or oral antidiabetic takers)
- Age (\> 65 years)
- Chronic Obstructive Pulmonary Disease (COPD in treatment with inhalers).
Exclusion
- Non-compliance with the inclusion criteria
- Conversion to laparotomy during the intervention
- Non-acceptance by the patient to participate in the study,
- Loss to follow-up.
Key Trial Info
Start Date :
January 6 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 4 2020
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT04341805
Start Date
January 6 2018
End Date
January 4 2020
Last Update
April 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marta
Elche, Alicante, Spain, 03203